NMNelly Mejia

Nelly Mejia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nelly Mejia has a total of 77 co-authors. Here are the top co-authors by number of shared publications:

  • Taiwo Abimbola

    U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA

    5 shared publications
  • Sarah W Pallas

    Global Immunization Division, US Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA

    4 shared publications
  • Denise O Garrett

    Applied Epidemiology, Sabin Vaccine Institute, Washington, DC, USA

    3 shared publications
  • Kashmira Date

    Global Immunization Division, US Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA

    3 shared publications
  • Anagha Loharikar

    World Health Organization, Ethiopia Country Office , UNECA Compound, Zambezi Building, Addis Ababa

    2 shared publications
  • Ebba Abate

    Global One Health LLC, The Ohio State University , Bole Road, Noah Plaza Building, 2nd Floor, Bole Sub-City, District-03, Addis Ababa, 1000

    2 shared publications

Latest Publications

  • Cost analysis of vaccine-preventable diseases surveillance in Ethiopia

    by Nelly Mejia, Aschalew Abayneh Workineh, Eden Dagnachew Zeleke, Senait Alemayehu Beshah, Roopa Darwar, Mesfin Wossen, Mikias Alayu, Leuel Lisanwork, Getnet Yimer, Kassech Sintayehu Molla, et al.

    Background: This study evaluated the cost of the vaccine-preventable diseases (VPD) surveillance system in Ethiopia to inform budgeting for disease detection, prevention, and control, and planning for transitions from donor funding. Methods: This cross-sectional retrospective, bottom-up micro-costing study collected data on resource utilization to conduct VPD surveillance during one fiscal year (2018–2019) in Ethiopia. The study covered 16 VPDs and costs from the government and partners perspective. Results: The estimated economic costs of VPD surveillance in Ethiopia were US$69.11 million or US$0.70 per capita, while financial costs were US$26.83 million or US$0.27 per capita. The largest economic cost was for labor (41.0%) and the largest financial cost was for supplies (36.9%). Resources were mostly allocated to integrated, general disease surveillance (economic: 54.6%; financial: 50.7%), followed by surveillance for measles and rubella (economic: 15.9%; financial: 22.5%) and polio (economic: 12.4%; financial: 15.7%). The main funder was the Ethiopian Ministry of Health (economic: 78.8%; financial 62.6%), including donor resources channeled through the ministry. Conclusions: Human resources were primary drivers of economic costs. Although the Ethiopian VPD surveillance system uses shared resources across multiple VPDs, resulting in scale efficiencies, and the Ethiopian government covers most of its economic costs, a substantial portion relies on direct external donor support.

  • Costing approaches for vaccine-preventable disease surveillance: Lessons from Ethiopia and Nepal

    by Roopa Darwar, Xiaoxian Huang, Aschalew Abayeneh, Senait Alemayehu Beshah, Minal K. Patel, Eden Dagnachew Zeleke, Mesfin Wossen, Mikias Alayu, Leuel Lisanwork, Benjamin A. Dahl, et al.


  • Open Access

    Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal

    by Timothy Brennan, Anna Hidle, Reena H. Doshi, Qian An, Anagha Loharikar, Rebecca Casey, Ousseynou Badiane, Alassane Ndiaye, Aliou Diallo, Jerlie Loko Roka, et al.


  • Open Access

    Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohorts

    by Anna Hidle, Timothy Brennan, Julie Garon, Qian An, Anagha Loharikar, Joan Marembo, Portia Manangazira, Nelly Mejia, Taiwo Abimbola


  • Open Access

    Typhoid and Paratyphoid Cost of Illness in Pakistan: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II

    by Nelly Mejia, Farah Qamar, Mohammad T Yousafzai, Jamal Raza, Denise O Garrett, Kashmira Date, Taiwo Abimbola, Sarah W Pallas

    Background: The objective of this study was to estimate the cost of illness from enteric fever (typhoid and paratyphoid) at selected sites in Pakistan. Methods: We implemented a cost-of-illness study in 4 hospitals as part of the Surveillance for Enteric Fever in Asia Project (SEAP) II in Pakistan. From the patient and caregiver perspective, we collected direct medical, nonmedical, and indirect costs per case of enteric fever incurred since illness onset by phone after enrollment and 6 weeks later. From the health care provider perspective, we collected data on quantities and prices of resources used at 3 of the hospitals, to estimate the direct medical economic costs to treat a case of enteric fever. We collected costs in Pakistani rupees and converted them into 2018 US dollars. We multiplied the unit cost per procedure by the frequency of procedures in the surveillance case cohort to calculate the average cost per case. Results: We collected patient and caregiver information for 1029 patients with blood culture–confirmed enteric fever or with a nontraumatic terminal ileal perforation, with a median cost of illness per case of US $196.37 (IQR, US $72.89–496.40). The median direct medical and nonmedical costs represented 8.2% of the annual labor income. From the health care provider perspective, the estimated average direct medical cost per case was US $50.88 at Hospital A, US $52.24 at Hospital B, and US $11.73 at Hospital C. Conclusions: Enteric fever can impose a considerable economic burden in Pakistan. These new estimates of the cost of illness of enteric fever can improve evaluation and modeling of the costs and benefits of enteric fever prevention and control measures, including typhoid conjugate vaccines.


  • Open Access

    Typhoid and Paratyphoid Cost of Illness in Bangladesh: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II

    by Nelly Mejia, Sarah W Pallas, Samir Saha, Jamal Udin, K M Ishtiaque Sayeed, Denise O Garrett, Kashmira Date, Taiwo Abimbola

    Background: We conducted a cost of illness study to assess the economic burden of pediatric enteric fever (typhoid and paratyphoid) in Bangladesh. Results can inform public health policies to prevent enteric fever. Methods: The study was conducted at 2 pediatric health facilities in Dhaka. For the patient and caregiver’s perspective, we administered questionnaires on costs incurred from illness onset until the survey dates to caregivers of patients with blood culture positive cases at enrollment and 6 weeks later to estimate the direct medical, direct nonmedical, and indirect costs. From the perspective of the health care provider, we collected data on quantities and prices of resources used by the 2 hospitals to estimate the direct medical economic costs to treat a case of enteric fever. We collected costs in Bangladeshi takas and converted them into 2018 US dollars. We multiplied the unit cost per procedure by the frequency of procedures in the surveillance case cohort to calculate the average cost per case. Results: Among the 1772 patients from whom we collected information, the median cost of illness per case of enteric fever from the patient and caregiver perspective was US $64.03 (IQR: US $33.90 –$173.48). Median direct medical and nonmedical costs per case were 3% of annual labor income across the sample. From the perspective of the healthcare provider, the average direct medical cost per case was US $58.64 (range: US $37.25 at Hospital B, US $73.27 at Hospital A). Conclusions: Our results show substantial economic burden of enteric fever in Bangladesh, with higher costs for patients receiving inpatient care. As antimicrobial resistance increases globally, the cost of illness could increase, due to more expensive and potent drugs required for treatment.


  • Open Access

    Typhoid and Paratyphoid Cost of Illness in Nepal: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II

    by Nelly Mejia, Taiwo Abimbola, Jason R Andrews, Krista Vaidya, Dipesh Tamrakar, Sailesh Pradhan, Rajani Shakya, Denise O Garrett, Kashmira Date, Sarah W Pallas

    Background: Enteric fever is endemic in Nepal and its economic burden is unknown. The objective of this study was to estimate the cost of illness due to enteric fever (typhoid and paratyphoid) at selected sites in Nepal. Methods: We implemented a study at 2 hospitals in Nepal to estimate the cost per case of enteric fever from the perspectives of patients, caregivers, and healthcare providers. We collected direct medical, nonmedical, and indirect costs per blood culture–confirmed case incurred by patients and their caregivers from illness onset until after enrollment and 6 weeks later. We estimated healthcare provider direct medical economic costs based on quantities and prices of resources used to diagnose and treat enteric fever, and procedure frequencies received at these facilities by enrolled patients. We collected costs in Nepalese rupees and converted them into 2018 US dollars. Results: We collected patient and caregiver cost of illness information for 395 patients, with a median cost of illness per case of $59.99 (IQR, $24.04–$151.23). Median direct medical and nonmedical costs per case represented ~3.5% of annual individual labor income. From the healthcare provider perspective, the average direct medical economic cost per case was $79.80 (range, $71.54 [hospital B], $93.43 [hospital A]). Conclusions: Enteric fever can impose a considerable economic burden on patients, caregivers, and health facilities in Nepal. These new estimates of enteric fever cost of illness can improve evaluation and modeling of the costs and benefits of enteric fever–prevention measures.


  • Open Access

    Methodological Considerations for Cost of Illness Studies of Enteric Fever

    by Nelly Mejia, Enusa Ramani, Sarah W Pallas, Dayoung Song, Taiwo Abimbola, Vittal Mogasale

    This article presents a selection of practical issues, questions, and tradeoffs in methodological choices to consider when conducting a cost of illness (COI) study on enteric fever in low- to lower-middle-income countries. The experiences presented are based on 2 large-scale COI studies embedded within the Surveillance for Enteric Fever in Asia Project II (SEAP II), in Bangladesh, Nepal, and Pakistan; and the Severe Typhoid Fever Surveillance in Africa (SETA) Program in Burkina Faso, Ethiopia, Ghana, and Madagascar. Issues presented include study design choices such as controlling for background patient morbidity and healthcare costs, time points for follow-up, data collection methods for sensitive income and spending information, estimating enteric fever–specific health facility cost information, and analytic approaches in combining patient and health facility costs. The article highlights the potential tradeoffs in time, budget, and precision of results to assist those commissioning, conducting, and interpreting enteric fever COI studies.


  • Calculating the Gross Regional Product of the Kurdistan Region -- Iraq

    by Shmuel Abramzon, Nicholas Burger, Peter Glick, Krishna Kumar, Cheryl Montemayor, Nelly Mejia, Shanthi Nataraj, Francisco Perez-Arce, Claude Setodji

    Estimates the gross regional product (GRP) of the Kurdistan Region -- Iraq in 2012 (excluding natural resources) and describes efforts to set up a system for data collection and analysis to support future annual GRP calculation.